J. Hamblin - Concepedia

Concepedia

Author

J. Hamblin

GlaxoSmithKline (United Kingdom)

Also Known As

Hamblin, J., Hamblin, J.N., J Nicole Hamblin, J. HAMBLIN, J. Hamblin, J. Nicole Hamblin, J.N Hamblin, J.N. Hamblin, Jacqueline Hamblin

61

Publications

1.5K

Citations

19

H-Index

61

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)University of Warwick Age UK Babraham Institute University of Leicester

JH

About

J. Hamblin is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	576
2	Natural Sciences	10	10	698
3	Biochemistry	8	8	440
4	Engineering	7	7	540
5	Allergy	1	1	130

J. Hamblin

×

28

Publications

1.5K

Citations

19

H-Index

	Year	Citations
An inexpensive approach to supramolecular architecture Michael J. Hannon, C.L. Painting, Alexander Jackson, Chemical Communications Combinatorial ChemistrySupramolecular AssemblySupramolecular ArchitecturesSupramolecular ArchitectureEngineering	1997	185
Possible Role of Phytohaemagglutinin in Phaseolus vulgaris L. J. Hamblin, Sidney P. Kent Nature New Biology BiologyBiosynthesisEngineeringBotanyNatural Sciences	1973	132
Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease Kenneth Down, Augustin Amour, Ian T. Baldwin, Journal of Medicinal Chemistry AsthmaAcute Lung InjuryPi3kδ PotencyInflammatory Lung DiseaseLung Inflammation	2015	130
Dimeric Zanamivir Conjugates with Various Linking Groups Are Potent, Long-Lasting Inhibitors of Influenza Neuraminidase Including H5N1 Avian Influenza Simon J. F. Macdonald, Rachel Cameron, Derek A. Demaine, Journal of Medicinal Chemistry Medicinal ChemistryMedicinePlaque Reduction AssaysAntiviral Drug DevelopmentDimeric Zanamivir Conjugates	2005	87
Potent and Long-Acting Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a Once-Weekly Dosing Regimen Simon J. F. Macdonald, Keith G. Watson, Rachel Cameron, Antimicrobial Agents and Chemotherapy Medicinal ChemistryAntiviral CompoundMedicineAntiviral TherapyVirology	2004	80
Directed one-pot syntheses of enantiopure dinuclear silver(i) and copper(i) metallo-supramolecular double helicates J. Hamblin, L.J. Childs, Nathaniel W. Alcock, Journal of the Chemical Society Dalton Transactions Materials ScienceInorganic ChemistryInorganic SynthesisEngineeringMetallo-supramolecular Double Helicates	2001	74
Triple helicates and planar dimers arising from silver(i) coordination to directly linked bis-pyridylimine ligands J. Hamblin, Alexander Jackson, Nathaniel W. Alcock, Journal of the Chemical Society Dalton Transactions EngineeringOrganic ChemistryChemistryPyridine-azine ClassInorganic Compound	2002	73
Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors J. Hamblin, Tony D. Angell, Stuart P. Ballantine, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryNovel Structural ClassBiochemistryMedicineRational Drug Design	2008	71
PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner Anne‐Katrien Stark, Anita Chandra, Krishnendu Chakraborty, Nature Communications	2018	70
Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD Anthony Cahn, J. Hamblin, Malcolm Begg, Pulmonary Pharmacology & Therapeutics	2017	68

Page 1